Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002712
Accepted
2025-08-25 00:15:05
Documents
1
Effectiveness Date
2025-08-22

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-25-002712.txt   1982
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286802 | Film No.: 251247791
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)